Online Database of Chemicals from Around the World
| Hangzhou Verychem Science And Technology Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
 | www.verychem.com | |||
 | +86 (571) 8816-2785 +86 13606544505 | |||
 | +86 (571) 8816-2787 | |||
 | lucy@verychem.com | |||
| Chemical manufacturer since 2004 | ||||
| chemBlink Massive supplier since 2021 | ||||
| Zhejiang Xianju Xianle Pharmaceutical Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
| www.xianle.com | |||
| +86 (576) 8778-9188 | |||
| +86 (576) 8779-3388 | |||
| zhujian@xianle.com | |||
| Chemical manufacturer since 1995 | ||||
| chemBlink Standard supplier since 2009 | ||||
| BOC Sciences | USA | Inquire | ||
|---|---|---|---|---|
| www.bocsci.com | |||
| +1 (631) 485-4226 | |||
| +1 (631) 614-7828 | |||
| info@bocsci.com | |||
| Chemical manufacturer | ||||
| chemBlink Standard supplier since 2010 | ||||
| Hangzhou Leap Chem Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
| www.leapchem.com | |||
| +86 (571) 8771-1850 | |||
| market19@leapchem.com | |||
 | QQ Chat | |||
| Chemical manufacturer since 2006 | ||||
| chemBlink Standard supplier since 2015 | ||||
| Finetech Industry Limited | China | Inquire | ||
|---|---|---|---|---|
| www.finetechchem.com | |||
| +86 (27) 8746-5837 +86 18971612321 | |||
| +86 (27) 8777-2287 | |||
| sales@finetechnology-ind.com | |||
| QQ Chat | |||
| Chemical manufacturer since 2009 | ||||
| chemBlink Standard supplier since 2019 | ||||
| Classification | Biochemical >> Inhibitor >> Endocrinology & hormones >> Estrogen/progestogen receptor inhibitor |
|---|---|
| Name | Depofemin |
| Synonyms | Estra-1,3,5(10)-triene-3,17beta-diol 17-cyclopentanepropionate; beta-Estradiol 17-cypionate |
| Molecular Structure |  |
| Molecular Formula | C26H36O3 |
| Molecular Weight | 396.57 |
| CAS Registry Number | 313-06-4 |
| EC Number | 206-237-8 |
| Hazard Symbols |   T;Xi Details | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Risk Statements | R20/21/22;R36/37/38;R45;R46;R61 Details | ||||||||||||||||||||||||||||
| Safety Statements | S22;S26;S36/37/39;S45;S53 Details | ||||||||||||||||||||||||||||
| Hazard Classification | |||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||
| SDS | Available | ||||||||||||||||||||||||||||
| Market Analysis Reports |
| List of Reports Available for Depofemin |
